Stephens Consulting’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-25
Closed -$416 1187
2025
Q1
$416 Buy
+25
New +$416 ﹤0.01% 993